BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30083832)

  • 1. Prognostic Significance of Tumor Deposits in Stage III Colon Cancer.
    Mirkin KA; Kulaylat AS; Hollenbeak CS; Messaris E
    Ann Surg Oncol; 2018 Oct; 25(11):3179-3184. PubMed ID: 30083832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Tumor Deposits on Oncologic Outcomes in Stage III Colon Cancer.
    Wong-Chong N; Motl J; Hwang G; Nassif GJ; Albert MR; Monson JRT; Lee L
    Dis Colon Rectum; 2018 Sep; 61(9):1043-1052. PubMed ID: 30086053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer.
    Al Sahaf O; Myers E; Jawad M; Browne TJ; Winter DC; Redmond HP
    Dis Colon Rectum; 2011 Aug; 54(8):982-8. PubMed ID: 21730787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
    Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
    J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Tumor Deposits in Combination with Lymph Node Metastasis in Stage III Colon Cancer: A Propensity Score Matching Study.
    Zheng P; Lai C; Yang W; Chen Z
    Am Surg; 2020 Feb; 86(2):164-170. PubMed ID: 32167047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancer.
    Hong KD; Lee SI; Moon HY
    J Surg Oncol; 2011 Apr; 103(5):406-10. PubMed ID: 21400524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic comparison between number and distribution of lymph node metastases in patients with right-sided colon cancer.
    Kim CH; Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2014 Apr; 21(4):1361-8. PubMed ID: 24366417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of occult metastases in colon cancer.
    Merrie AE; van Rij AM; Dennett ER; Phillips LV; Yun K; McCall JL
    Dis Colon Rectum; 2003 Feb; 46(2):221-31. PubMed ID: 12576896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
    Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer.
    Chen SL; Steele SR; Eberhardt J; Zhu K; Bilchik A; Stojadinovic A
    Ann Surg; 2011 Jan; 253(1):82-7. PubMed ID: 21135690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer.
    Sjo OH; Merok MA; Svindland A; Nesbakken A
    Dis Colon Rectum; 2012 Mar; 55(3):307-15. PubMed ID: 22469798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
    Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
    Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
    Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
    Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.
    Vather R; Sammour T; Kahokehr A; Connolly AB; Hill AG
    Ann Surg Oncol; 2009 Mar; 16(3):585-93. PubMed ID: 19116751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer.
    Yang L; Xiong Z; Xie Q; He W; Liu S; Kong P; Jiang C; Guo G; Xia L
    BMC Cancer; 2018 May; 18(1):558. PubMed ID: 29751794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity of predicting prognosis by the lymph node ratio in node-positive colon cancer.
    Sugimoto K; Sakamoto K; Tomiki Y; Goto M; Kojima Y; Komiyama H
    Dig Surg; 2013; 30(4-6):368-74. PubMed ID: 24107470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)
    Cohen R; Shi Q; Meyers J; Jin Z; Svrcek M; Fuchs C; Couture F; Kuebler P; Ciombor KK; Bendell J; De Jesus-Acosta A; Kumar P; Lewis D; Tan B; Bertagnolli MM; Philip P; Blanke C; O'Reilly EM; Shields A; Meyerhardt JA
    Ann Oncol; 2021 Oct; 32(10):1267-1275. PubMed ID: 34293461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.